Figure 6.
Time to first moderate or severe exacerbation over the 26-week treatment period.
Notes: *P < 0.001 versus placebo; †P = 0.027 versus placebo; ‡P = 0.003 versus placebo.
Abbreviations: F, formoterol; MF, mometasone furoate; MF/F, mometasone furoate/formoterol fixed-dose combination formulation.